ResearcherInsermActive in the last 2 years
Maryam Karimi
Matched on ORCID iD 0000-0003-3301-8795; OpenAlex author ID A5102875053. Sources: OpenAlex.
Their work
- Papers
- 3 (first author 0, last author 3)
- Trials
- 0
- Grants
- 0
- Labs led
- 1
- Collaborators
- 2
2025: 1 paper · 2026: 2 papers
Papers 3
- Development and internal validation of a clinical risk prediction model for pancreatic ductal adenocarcinoma in the UK Biobank. Last author DOI 10.1016/j.ejca.2026.116767↗
- Correction: Identifying health conditions associated with an increased risk of pancreatic ductal adenocarcinoma at medium term in nationwide electronic health … Last author DOI 10.1038/s41416-026-03597-6↗
- Identifying health conditions associated with an increased risk of pancreatic ductal adenocarcinoma at medium term in nationwide electronic health records of p… Last author DOI 10.1038/s41416-025-03172-5↗
Closest collaborators
The 2 strongest of 2 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.
- Elie Rassy · 3 shared papers, 2025–2026 · strength 0.90
- Paper Development and internal validation of a clinical risk prediction model for pancreatic ductal adenocarcinoma in the UK … DOI 10.1016/j.ejca.2026.116767↗
- Paper Correction: Identifying health conditions associated with an increased risk of pancreatic ductal adenocarcinoma at medi… DOI 10.1038/s41416-026-03597-6↗
- Paper Identifying health conditions associated with an increased risk of pancreatic ductal adenocarcinoma at medium term in n… DOI 10.1038/s41416-025-03172-5↗
- Alice Boilève · 3 shared papers, 2025–2026 · strength 0.90
- Paper Development and internal validation of a clinical risk prediction model for pancreatic ductal adenocarcinoma in the UK … DOI 10.1016/j.ejca.2026.116767↗
- Paper Correction: Identifying health conditions associated with an increased risk of pancreatic ductal adenocarcinoma at medi… DOI 10.1038/s41416-026-03597-6↗
- Paper Identifying health conditions associated with an increased risk of pancreatic ductal adenocarcinoma at medium term in n… DOI 10.1038/s41416-025-03172-5↗
How to reach this person
A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.